The blood plasma market is experiencing significant expansion across the Middle East and the Americas, driven by rising demand for plasma-derived therapies, increasing prevalence of chronic diseases, and advancements in fractionation technologies. Blood plasma, a vital component of human blood, is widely used in treating immunodeficiency disorders, hemophilia, and other life-threatening...